The Therapeutic Effects of Fenofibrate on Blood Serum Lipid in Type II Diabetic Patients in El-beida, Libya
The risks of dyslipidemia and cardiovascular diseases are well known to be increased in diabetic patients. Moreover, the therapeutic response of fenofibrate drug on blood serum lipid is also known. However, previous studies did not compare the outcomes of fenofibrate on blood serum levels in patien...
Main Authors: | Yahya Saber E. Mansour, Nusieba A. Mohammed Ibrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
Omar Al-Mukhtar University
2019-09-01
|
Series: | مجلة المختار للعلوم |
Subjects: | |
Online Access: | https://omu.edu.ly/journals/index.php/mjsc/article/view/280 |
Similar Items
-
Radiosensitizing capacity of fenofibrate in glioblastoma cells depends on lipid metabolism
by: Bayan Alkotub, et al.
Published: (2025-02-01) -
Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway
by: Tong Zhou, et al.
Published: (2022-12-01) -
The Effectiveness and Safety of Fenofibrate and Saroglitazar in the Treatment of Diabetic Dyslipidemia
by: Bakhtawar Farooq, et al.
Published: (2024-05-01) -
Porous Nanostructure, Lipid Composition, and Degree of Drug Supersaturation Modulate In Vitro Fenofibrate Solubilization in Silica-Lipid Hybrids
by: Ruba Almasri, et al.
Published: (2020-07-01) -
Development and validation of bioanalytical UHPLC-UV method for simultaneous analysis of unchanged fenofibrate and its metabolite fenofibric acid in rat plasma: Application to pharmacokinetics
by: Rayan G. Alamri, et al.
Published: (2017-01-01)